INTRODUCTION
We have previously demonstrated that neutrophil cathepsin G, like thrombin, is a strong platelet agonist which exhibits saturable, reversible binding to platelets, characteristic of the involvement of a specific receptor [1, 2] . In addition, cathepsin G and thrombin are the only platelet agonists that are proteases, and most of the biological actions of both cathepsin G and thrombin require the catalytic activity of the enzymes. In particular, aggregation and stimulus-response coupling in platelets are abolished when the proteolytic activity of either cathepsin G or thrombin is blocked or neutralized [1] [2] [3] [4] . The thrombin receptor has been cloned and sequenced and shown to possess seven transmembrane domains characteristic of all members of the family of G-protein-linked receptors [5] . However, unlike any other receptor yet described, proteolysis of the extracellular Nterminal receptor domain is required for activation. Cleavage of the thrombin receptor at Arg4l exposes a new N-terminus which then functions as a tethered ligand to activate cells by binding to a site on the receptor [5, 6] . The binding site for thrombin includes a region of the N-terminus of the receptor distal to the cleavage site which bears a strong resemblance to hirudin and functions to bind thrombin via its anion exosite [6] [7] [8] . A synthetic peptide composed of receptor residues Ser42-Phe55 (thrombin receptor peptide; TRP42155) has been shown to function as a full platelet agonist [5, 9] . However, only the first six amino acids of this 14-residue peptide are required for activity [10, 11] . TRP42155 has also been shown to activate human endothelial cells [12] and hamster fibroblasts [13] , suggesting that endothelial cells, fibroblasts and platelets share a structurally similar thrombin receptor.
Activation of the thrombin receptor by this novel intramolecular rearrangement raises the question of whether a family of similar G-protein-coupled protease receptors might exist. Since the catalytic activity of cathepsin G is mandatory for platelet stimulation, it is highly probable that platelet activation exhibiting an elevation in cytosolic Ca2+ concentration but did not respond to cathepsin G; and (c) platelets pretreated with neutrophil elastase failed to respond to thrombin but responded when rechallenged by cathepsin G. Thrombin and cathepsin G exhibit heterologous desensitization that is potentiated by okadaic acid and is attenuated by staurosporine, indicating that phosphorylation of serine/threonine residues is important for desensitization and that protein kinase C may be involved. Since catalytic activity of cathepsin G is required for platelet stimulation, it is probable that platelet activation by cathepsin G requires receptor proteolysis and that a tethered ligand mechanism is involved, suggesting that platelets may possess a family of protease receptors.
by cathepsin G requires receptor proteolysis and that a tethered ligand mechanism is involved. While our previous results indicate that cathepsin G strongly resembles thrombin in its ability to activate platelets [1] , data presented here suggest that these two agonists function through distinct receptors rather than through a single receptor which is differentially cleaved to yield two different tethered ligands. Evidence indicating that platelets possess different receptors for thrombin and cathepsin G suggests that platelets possess a family of protease receptors.
MATERIALS AND METHODS Materials
Monoclonal antibody ATAP138, directed against the SFLLR-NPNDKYEPF sequence of the thrombin receptor (Ser42-Phe55), was a gift from Dr. Lawrence Brass (University of Pennsylvania, Philadelphia, PA, U.S.A.), and a-thrombin was a generous gift from Dr. John Fenton (Albany Medical College, Albany, NY, U.S.A.). Okadaic acid was obtained from Gibco or from Kamiya Biomedical Company, and staurosporine was purchased from Kamiya Biomedical Company. TRP42155 was purchased from Bacham Bioscience Inc., Philadelphia, PA, U.S.A.
Preparation and labelling of platelets
Human blood was obtained from healthy volunteers and collected into acid-citrate dextose. The platelet-rich plasma, obtained by centrifugation at 180 g for 20 min at room temperature, was re-centrifuged at 800 g for 15 min at room temperature to obtain a platelet pellet. The platelet pellet was resuspended in 10 ml of plasma and the platelets were incubated at 37°C with 3 ,M fura-2-acetoxymethyl ester for 45 min and with 1 ,uM 5 Purification of neutrophil cathepsin G and elastase Buffy coat leucocytes were used to isolate cathepsin G from neutrophil granules by the method of Baugh and Travis [14] . Granule extracts were subjected to sequential aprotininSepharose and CM-Sephadex chromatographies [15] . Protein concentration was determined using the BCA protein assay (Pierce) with BSA as standard, as well as by absorbance at 280 nm. The purity of cathepsin G and elastase was assessed by specific substrate hydrolysis and by both SDS and nondenaturing acid gel electrophoresis as described previously [1] . Based on these criteria, cathepsin G was totally devoid of neutrophil elastase and vice versa. Cathepsin G and elastase enzymic activities were measured spectrophotometrically at 37°C using N-succinyl-(Ala)2-Pro-Phe-p-nitroanilide and methoxysuccinyl-(Ala)2-Pro-Val-p-nitroanilide respectively as substrates, according to the method of Nakajima et al. [16] .
Measurement of 5-hydroxytryptamine release Dense granule secretion was measured in 5-hydroxy[14C]-tryptamine-labelled platelets supplemented with imipramine. Secretion was stopped in formaldehyde-EDTA according to the method of Costa and Murphy [17] and samples of the supernatants were added to scintillation fluid. In each set of experiments the total 5-hydroxytryptamine content of the platelets was measured by adding platelet suspension to the stopping solution, from which a sample was then transferred directly to the counting solution. Release of 5- 5 -hydroxytryptamine release in the presence of PC/CK and aspirin, the ionophore could also be used to assess the amount of residual intracellular calcium without contributing to agonist-induced dense granule secretion (see Figure 5 ; [19] [5, 6] . As noted in Figure 1 [20, 21] . On the other hand, we [22] have observed that neutrophil elastase potentiates platelet responses elicited by low (suboptimal) concentrations of cathepsin G where platelet activation by cathepsin G is partially dependent on amplification by released ADP and thromboxane A2. We have exploited the effects of elastase on thrombin-and cathepsin G-induced platelet responses to examine differences between the receptor(s) for these two agonists. (Since the experiments described here were performed in the presence of PC/CK and aspirin, potentiation of cathepsin G-induced responses by neutrophil elastase was not observed.) As seen in Figure 3 , platelets which were unresponsive to thrombin following elastase pretreatment responded when rechallenged with cathepsin G. Elastase had no effect on responses to U46619 and, similar to fibroblasts, elastase had no effect on TRP42155-induced platelet responses. Both potentiation of cathepsin G and inhibition of thrombin-induced responses require catalytically active elastase since phenylmethanesulphonyl fluoride-inhibited elastase had no effect on cell activation. 
Role of protein phosphorylation in platelet desensitization
To determine whether phosphorylation plays a role in cathepsin G-induced cathepsin G desensitization and in thrombin-induced thrombin desensitization, okadaic acid was used to inhibit protein phosphatases. As seen in Figure 4( staurosporine was used in all subsequent experiments (e.g. see Figure 4b ). Preincubation of platelets with staurosporine prolonged the duration of the calcium signals by slowing the rate of calcium resequestration, and additionally inhibited the amount of 5-hydroxytryptamine released from dense granules [25] [26] [27] . Staurosporine also tended to increase the amount of calcium mobilized in response to a second addition of the same agonist, suggesting that protein kinase C plays a role in desensitization to thrombin or to cathepsin G.
Cross-desensitization of cathepsin G and thrombin responses in platelets Platelets were examined for heterologous desensitization either by stimulating cells with thrombin followed by restimulation with cathepsin G or vice versa. Concentrations were selected such that the cells exhibited specific desensitization to the initial agonist. As seen in Figure 5 , [1] . Thrombin, a trypsin-like enzyme, is extremely specific and, with rare exceptions, cleaves peptide bonds to arginine in both natural and synthetic substrates [28] . Cathepsin G is approximately one to two orders of magnitude less active than leucocyte elastase and other serine proteases, including chymotrypsin and trypsin, in its ability to degrade numerous proteins [29, 30] G is further underscored by the fact that, although cathepsin G exhibits chymotrypsin-like specificity, it differs from chymotrypsin in that it can activate platelets whereas chymotrypsin cannot [3] . Thus [Ca2l],, but both failed to respond to cathepsin G. TRP42155 has also been shown to activate hamster fibroblasts [13] , suggesting that the fibroblast thrombin receptor is activated by a tethered ligand mechanism and that fibroblasts and platelets share a structurally similar receptor. Consistent with this conclusion is the observation here that pretreatment of human fibroblasts with leucocyte elastase attenuated fibroblast responses to thrombin and, also similar to platelets, elastase had no effect on TRP42155-induced responses.
The inhibition of thrombin-induced calcium mobilization by pretreatment with neutrophil elastase is consistent with the demonstration by other investigators that leucocyte elastase is associated with hydrolysis of glycoprotein lb (GPIb) and with a decrease in the number of high-affinity thrombin binding sites [20, 21] . Although it is not known how GPIb and the cloned thrombin receptor relate in terms of platelet signal transduction, it may be relevant that residues 269-287 in GPIb are rich in negatively charged amino acids [31] . It is possible that thrombin binding to these residues via its anion exosite enhances stimulusresponse coupling mediated by the thrombin receptor. Elastase cleavage of GPIb on the C-terminal side of this binding region would eliminate the high-affinity thrombin binding domain, thereby leading to diminished thrombin responsiveness. It is also noteworthy that elastase had no effect on TRP42155-induced platelet or fibroblast responses, suggesting that, in addition to cleaving GPIb, elastase may also possibly cleave the thrombin receptor on the C-terminal side of Ser42, thereby precluding formation of the tethered ligand.
Homologous desensitization decreases the responsiveness to a second round of stimulation by the same agonist and is diagnostic of different receptors; heterologous desensitization decreases the response to multiple agonists but does not indicate whether the receptors are the same or different [32] . Exposure of platelets to thrombin is known to make them less sensitive to subsequent stimulation by thrombin [23, 24] . We demonstrate here that, as with thrombin, platelets pretreated with cathepsin G become unresponsive when re-exposed to the same ligand. In addition, platelets incubated with cathepsin G exhibited attenuated calcium and secretion responses when rechallenged by thrombin, and vice versa. Desensitization to cathepsin G and thrombin was dependent on the concentration of the initial agonist, consistent with a proteolytic event. Moreover, desensitization was increased by okadaic acid and was decreased by staurosporine, suggesting that phosphorylation of serine/threonine residues is important and that protein kinase C may play a role in desensitization.
These results are consistent with the observations of Brass [33] that protein kinase C plays a limited role in thrombin desensitization in human erythroleukaemia (HEL) cells. Although staurosporine is a potent protein kinase C inhibitor, it can also inhibit other protein kinases [34] . Consequently, the effect of staurosporine suggests, but does not prove, that protein kinase C is involved in the desensitization of cathepsin G-and thrombininduced platelet responses. Cathepsin G and thrombin also attenuated platelet responses to the thromboxane A2-mimetic U46619 
